Canadian Digestive Health Foundation Public Impact Series 3: Irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact

Canadian Journal of Gastroenterology

Volumn 26, Issue 5, 2012, Pages 252-256

  Fedorak, Richard N ^a   Vanner, Stephen J ^b   Paterson, William G ^b   Bridges, Ron J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Burden of disease; Canada; Chronic disease; Digestive disease; Epidemiology; Irritable bowel syndrome

Indexed keywords

ANTIDIARRHEAL AGENT; LAXATIVE; NON PRESCRIPTION DRUG; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ABSENTEEISM; ANXIETY DISORDER; CANADA; CHRONIC DISEASE; COMORBIDITY; DIAGNOSTIC TEST; DIET; DRUG COST; EMERGENCY CARE; EXERCISE; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; INCIDENCE; IRRITABLE COLON; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MEDICAL FEE; META ANALYSIS (TOPIC); MORTALITY; PATIENT CARE; PLACEBO EFFECT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 84861174122     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/861478     Document Type: Review

References (51)

1. Thabane M, Simunovic M, khtar-Danesh N, et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol 2010;105:933-9.
2. Chang JY, Locke GR, III, McNally MA, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 2010;105:822-32.
3. Grundmann O, Yoon SL. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners. J Gastroenterol Hepatol 2010;25:691-9.
4. Malinen E, Krogius-Kurikka L, Lyra A, et al. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010;16:4532-40.
5. O'Mahony SM, Bulmer DC, Coelho AM, et al. 5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 2010;22:573-8, e124.
6. Zhou Q, Souba WW, Croce CM, et al. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2010;59:775-84.
7. Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 2010;156:3205-15.
8. Elsenbruch S. Abdominal pain in irritable bowel syndrome: A review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011;25:386-94.
9. Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: A family case-control study. Am J Gastroenterol 2010;105:833-41.
10. Sperber AD, Dekel R. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil 2010;16:113-9.
11. Keohane J, O'Mahony C, O'Mahony L, et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation? Am J Gastroenterol 2010;105:1788-94.
12. Sperber AD, Shvartzman P, Friger M, et al. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 2005;17:207-11. (Pubitemid 40476681)
13. Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: Are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007;19:441-7. (Pubitemid 46725749)
14. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: Prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23-30. (Pubitemid 24227923)
15. Brun-Strang C, Dapoigny M, Lafuma A, et al. Irritable bowel syndrome in France: Quality of life, medical management, and costs: The Encoli study. Eur J Gastroenterol Hepatol 2007;19:1097-103. (Pubitemid 350130066)
16. Locke GR, III, Yawn BP, Wollan PC, et al. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther 2004;19:1025-31. (Pubitemid 38657384)
17. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:535-44. (Pubitemid 47174284)
18. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-50. (Pubitemid 44142459)
19. Statistics Canada - Health Statistics Division. Canadian Community Health Survey (CCHS) Cycle 4.1 2007-2008. Ottawa: Statistics Canada, 2009.
20. Statistics Canada - Health Statistics Division. Canadian Community Health Survey (CCHS) Cycle 3.1 2005. Ottawa: Statistics Canada, 2006.
21. Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35. (Pubitemid 34075042)
22. Li FX, Patten SB, Hilsden RJ, et al. Irritable bowel syndrome and health-related quality of life: A population-based study in Calgary, Alberta. Can J Gastroenterol 2003;17:259-63. (Pubitemid 36701307)
23. Drossman DA, Li Z, Andruzzi RD, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80. (Pubitemid 23271409)
24. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
25. Sandler RS, Drossman DA, Nathan HP, et al. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314-8. (Pubitemid 14092390)
26. Bentkover JD, Field C, Greene EM, et al. The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 1999;13:89A-96A.
27. Herman J, Pokkunuri V, Braham L, et al. Gender distribution in irritable bowel syndrome is proportional to the severity of constipation relative to diarrhea. Gend Med 2010;7:240-6.
28. Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: A family case-control study. Am J Gastroenterol 2010;105:833-41.
29. Boivin M. Socioeconomic impact of irritable bowel syndrome in Canada. Can J Gastroenterol 2001;15:8B-11B. (Pubitemid 33740478)
30. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria - a 10-year follow-up study. Aliment Pharmacol Ther 2010;32:670-80.
31. Lix LM, Yogendran MS, Shaw SY, et al. Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: A population-based investigation. BMC Health Serv Res 2010;10:31.
32. Fouad YM, Makhlouf MM, Khalaf H, et al. Is irritable bowel syndrome associated with chronic hepatitis C? J Gastroenterol Hepatol 2010;25:1285-8.
33. White DL, Savas LS, Daci K, et al. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther 2010;32:551-61.
34. Dong L, Dingguo L, Xiaoxing X, et al. An epidemiologic study of irritable bowel syndrome in adolescents and children in China: A school-based study. Pediatrics 2005;116:e393-e396. (Pubitemid 44336654)
35. Miele E, Simeone D, Marino A, et al. Functional gastrointestinal disorders in children: An Italian prospective survey. Pediatrics 2004;114:73-8. (Pubitemid 38857568)
36. Reshetnikov OV, Kurilovich SA, Denisova DV, et al. Prevalence of dyspepsia and irritable bowel syndrome among adolescents of Novosibirsk, western Siberia. Int J Circumpolar Health 2001;60:253-7.
37. Hyams JS, Burke G, Davis PM, et al. Abdominal pain and irritable bowel syndrome in adolescents: A community-based study. J Pediatr 1996;129:220-6. (Pubitemid 27483793)
38. Statistics Canada. CANSIM - Table 102-0531 - Deaths, by cause, Chapter XI: Diseases of the digestive system (K00 to K93), age group and sex, Canada, annual (2000-2006). 〈http://cansim2. statcan.gc.ca〉 (Accessed July 28, 2010).
39. Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:671-82. (Pubitemid 37271832)
40. Talley NJ, Zinsmeister AR, Melton LJ, III. Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
41. Maxion-Bergemann S, Thielecke F, Abel F, et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21-37. (Pubitemid 43197228)
42. Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice. CMAJ 1999;161:154-60. (Pubitemid 29375972)
43. Johannesson E, Simren M, Strid H, et al. Physical activity improves symptoms in irritable bowel syndrome: A randomized controlled trial. Am J Gastroenterol 2011;106:915-22.
44. Organisation for Economic Co-operation and Development (OECD). OECD Health Data 2009. 〈www.oecd.org〉 (Accessed January 2, 2011).
45. Ford A, Moayyedi, P. Meta-analysis: Factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010;32:144-58.
46. Spiegel BM, Kanwal F, Naliboff B, et al. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005;100:2262-73.
47. Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet 1997;350:1691-5.
48. Cole JA, Yeaw JM, Cutone JA, et al. The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome. Dig Dis Sci 2005;50:2268-75. (Pubitemid 43106380)
49. Canadian Institute for Health Information. Patient Cost Estimator 2008-2009. 〈www.cihi.ca〉 (Accessed January 2, 2011).
50. Statistics Canada. Economic Indicators, Table 281-0039. 〈www.statcan.gc.ca〉 (Accessed February 1, 2011).
51. Johansson PA, Farup PG, Bracco A, et al. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol 2010;10:31.